Cargando…

Cannabinoid and Opioid Receptor Affinity and Modulation of Cancer-Related Signaling Pathways of Machaeriols and Machaeridiols from Machaerium Pers.

Machaeriols and machaeridiols are unique hexahydrodibenzopyran-type aralkyl phytocannabinoids isolated from Machaerium Pers. Earlier studies of machaeriol A (1) and B (2) did not show any affinity for cannabinoid receptor 1 (CB1 or CNR1), although they are structural analogs of psychoactive hexahydr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muhammad, Ilias, Ibrahim, Mohammad A., Kumarihamy, Mallika, Lambert, Janet A., Zhang, Jin, Mohammad, Marwa H., Khan, Shabana I., Pasco, David S., Balachandran, Premalatha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361207/ https://www.ncbi.nlm.nih.gov/pubmed/37241903 http://dx.doi.org/10.3390/molecules28104162

Ejemplares similares

Antimicrobial Constituents from Machaerium Pers.: Inhibitory Activities and Synergism of Machaeriols and Machaeridiols against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus faecium, and Permeabilized Gram-Negative Pathogens
por: Muhammad, Ilias, et al.
Publicado: (2020)

Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways
por: Kumarihamy, Mallika, et al.
Publicado: (2022)

Novel Machaeriol Analogues as Modulators of Cannabinoid Receptors: Structure–Activity Relationships of (+)-Hexahydrocannabinoids and Their Isoform Selectivities
por: Haider, Saqlain, et al.
Publicado: (2021)

In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors
por: Pandey, Pankaj, et al.
Publicado: (2023)

Machaerium hirtum (Vell.) Stellfeld Alleviates Acute Pain and Inflammation: Potential Mechanisms of Action
por: Lopes, Juliana Agostinho, et al.
Publicado: (2020)

Crosstalk of Cancer Signaling Pathways by Cyclic Hexapeptides and Anthraquinones from Rubia cordifolia
por: Balachandran, Premalatha, et al.
Publicado: (2021)

Extracts from Pulsatilla patens target cancer-related signaling pathways in HeLa cells
por: Łaska, Grażyna, et al.
Publicado: (2021)

Pulsatilla vulgaris Inhibits Cancer Proliferation in Signaling Pathways of 12 Reporter Genes
por: Łaska, Grażyna, et al.
Publicado: (2023)

Affinity Assays for Cannabinoids Detection: Are They Amenable to On-Site Screening?
por: Puiu, Mihaela, et al.
Publicado: (2022)

Ethiopian Medicinal Plants Traditionally Used for the Treatment of Cancer, Part 2: A Review on Cytotoxic, Antiproliferative, and Antitumor Phytochemicals, and Future Perspective
por: Tesfaye, Solomon, et al.
Publicado: (2020)

QSAR Model for Predicting the Cannabinoid Receptor 1 Binding Affinity and Dependence Potential of Synthetic Cannabinoids
por: Lee, Wonyoung, et al.
Publicado: (2020)

Quantitative analysis of opioids and cannabinoids in wastewater samples
por: Jacox, Alethea, et al.
Publicado: (2017)

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020)

Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
por: Kumar, Vinod, et al.
Publicado: (2014)

Antinociceptive and Abuse Potential Effects of Cannabinoid/Opioid Combinations in a Chronic Pain Model in Rats
por: Alsalem, Mohammad, et al.
Publicado: (2019)

NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
por: Vanegas, Horacio, et al.
Publicado: (2010)

Alcohol, Cannabinoids, and Opioids Abuse and Dependence Among Psychiatric Inpatients
por: Habibisaravi, Reza, et al.
Publicado: (2015)

An answered call for aid? Cannabinoid clinical framework for the opioid epidemic
por: Hammaker, Krista, et al.
Publicado: (2023)

Analgesic Effects and Impairment in Locomotor Activity Induced by Cannabinoid/Opioid Combinations in Rat Models of Chronic Pain
por: Alsalem, Mohammad, et al.
Publicado: (2020)

Antiplasmodial and Cytotoxic Cytochalasins from an Endophytic Fungus, Nemania sp. UM10M, Isolated from a Diseased Torreya taxifolia Leaf
por: Kumarihamy, Mallika, et al.
Publicado: (2019)

Molecular framework for designing Fluoroclay with enhanced affinity for per- and polyfluoroalkyl substances
por: Yan, Bei, et al.
Publicado: (2023)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
por: Befort, Katia
Publicado: (2015)

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

Antimalarials and Phytotoxins from Botryosphaeria dothidea Identified from a Seed of Diseased Torreya taxifolia
por: Kumarihamy, Mallika, et al.
Publicado: (2020)

Receptor Binding Affinities of Synthetic Cannabinoids Determined by Non-Isotopic Receptor Binding Assay
por: Cha, Hye Jin, et al.
Publicado: (2019)

Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two
por: McPartland, John M., et al.
Publicado: (2017)

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
por: Brents, Lisa K., et al.
Publicado: (2011)

Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach
por: Niaz, Kamal, et al.
Publicado: (2017)

Functional activity of the cannabinoid 1 receptor is not affected by opioid antagonists in the rat brain
por: Lee, Heeseung
Publicado: (2013)

Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats
por: Díaz-Ruano, Susana, et al.
Publicado: (2019)

Consensus‐based recommendations for titrating cannabinoids and tapering opioids for chronic pain control
por: Sihota, Aaron, et al.
Publicado: (2020)

Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play
por: Manduca, Antonia, et al.
Publicado: (2016)

In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies
por: Fritzwanker, Sebastian, et al.
Publicado: (2023)

α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabissativa
por: Suttithumsatid, Wiwit, et al.
Publicado: (2022)

Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development
por: Ford, Benjamin M., et al.
Publicado: (2016)

Cannabinoids and Chronic Liver Diseases
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2022)

Critical interactions between opioid and cannabinoid receptors during tolerance and physical dependence development to opioids in the murine gastrointestinal tract: proof of concept
por: Szymaszkiewicz, Agata, et al.
Publicado: (2021)

Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum
por: Oude Ophuis, Ralph J. A., et al.
Publicado: (2014)

Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain
por: Bushlin, Ittai, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7lpsoinh3vr2d4a5vaq2p1eln1